Journal of the American College of Cardiology
-
J. Am. Coll. Cardiol. · Jan 2013
Randomized Controlled TrialPredicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score.
The aim of this study was to derive and validate a model to predict survival in candidates for HeartMate II (HMII) (Thoratec, Pleasanton, California) left ventricular assist device (LVAD) support. ⋯ The HMRS might be useful for mortality risk stratification in HMII candidates and may serve as an additional tool in the patient selection process.
-
J. Am. Coll. Cardiol. · Jan 2013
Readmissions after implantation of axial flow left ventricular assist device.
The purpose of this study was to determine the occurrence and causes of readmissions after implantation of axial flow left ventricular assist device (LVAD). ⋯ Readmission rates after axial flow LVAD implantation decrease during the first 6 months and then stabilize. The leading causes are bleeding, cardiac (heart failure and arrhythmia), infections, and thrombosis.